New hope for Parkinson's: can AP-472 cut down 'OFF' episodes?
Symptom relief
Recruiting now
This study tests an experimental drug called AP-472 in 150 people with Parkinson's disease who have 'OFF' episodes—times when their regular medication stops working well. Participants take AP-472 or a placebo alongside their usual levodopa for 8 weeks. The goal is to see if AP-47…
Phase: PHASE2 • Sponsor: Appello Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC